Christopher B. Hansen
( out of 655 reviews )

Christopher B. Hansen, MD

Languages spoken: English, French

Clinical Locations

Midvalley Health Center

Murray
801-581-2955

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955

  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 655 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    November 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Chris is great!

    November 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Thank you, Dr. Hansen, you are a wonderful person.

    November 27, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I highly recommend Dr. Hansen.

    November 27, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Christopher B Hansen is an exceptionally great dermatologist in every way. This time I especially appreciated his careful listening and explanation so I could better understand how my medications work. A+ as usual.

    November 27, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    He is exceptional!

    November 27, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    chip off the old block

    November 26, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Always includes me in decisions about my care. Great doctor.

    November 25, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Thank You for your time and concern for my health. I am treated with respect and caring by you and all of your team and I truly do appreciate all that you and your team do for me. Thank You...!!!!!

    November 21, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    The gal at the front desk is always so kind and friendly. I don't know her name. Dr. Hansen is the best. I've been driving from Midway Utah to Murray for years and years because of him. I've referred friends to him also.

    See More Patient Comments

  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Chief Resident Dermatology - University of Texas Southwestern Chief Resident
    Residency Dermatology - University of Texas Southwestern Medical School Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Research Fellow Dermatology - University of Utah - Dermatology Research Fellow
    Professional Medical Medicine - University of Utah M.D.
    Undergraduate French - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2024). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    2. Marcelus C, Jimenez A, Zussman J, Hansen CB, Sontheimer RD (2022). Questions raised by a case of adult-onset linear nodular scleroderma. Dermatol Online J, 28(5). (Read full article)
    3. Overbury RS, Stoddard GJ, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (2021). The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle. BMC Health Serv Res, 21(1), 913. (Read full article)
    4. Beshay A, Zussman J, Hansen C (2020). Recurrent erythematous patch on the upper arm. JAAD Case Rep, 6(12), 1214-1216. (Read full article)
    5. Winchester D, Duffin KC, Hansen C (2012). Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus, 21(9), 1007-10. (Read full article)
    6. Hansen CB, Dahle KW (2012). Cutaneous lupus erythematosus. Dermatol Ther, 25(2), 99-111. (Read full article)
    7. Gammon B, Hansen C, Costner MI (2011). Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. J Am Acad Dermatol, 65(4), 717-721.e2. (Read full article)
    8. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD (2011). A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol, 164(3), 465-72. (Read full article)
    9. Hansen CB, Callen JP (2010). Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther, 23(4), 341-9. (Read full article)

    Case Report

    1. Shah A, Bowen A, Hansen C (2020). Multifocal periungual granulation tissue related to ibrutinib therapy. JAAD Case Rep, 6(2), 149-151. (Read full article)

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
    2. Gonzalez CD, Hansen C, Clarke JT (2019). Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. [Letter to the editor]. J Am Acad Dermatol, 81(3), 859-860. (Read full article)